Evidence map›Paper›PMID 28546562›Full record

ReviewExperimental & molecular medicine2017

The interplay between host immune cells and gut microbiota in chronic inflammatory diseases.

Donghyun Kim, Melody Y Zeng, Gabriel Núñez

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Experimental & molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04032938 (Clinical and Multi-omics Study on Gut Microbiota in Critical Ill Patients After Cardiovascular Surgery Combined Cardiopulmonary Bypass With or Without Sepsis(CPB-MUL-GM Study)), which is not on this map. Cited by 100 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04032938 unknown statusnot on this mapstarted 2018, after this paper: background citation

Clinical and Multi-omics Study on Gut Microbiota in Critical Ill Patients After Cardiovascular Surgery Combined Cardiopulmonary Bypass With or Without Sepsis(CPB-MUL-GM Study): a Prospective Study Protocol

TypeobservationalSponsorPeking Union Medical College HospitalRan2018 to 2019Enrolled150ConditionsSepsis, Cardiopulmonary BypassArmsextracorporeal circulation during cardiac surgery
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 3 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Secretory phospholipase ACommunications biology · 2025
    Article
  9. Review
  10. Article
  11. Metabolites · 2025
    Article
  12. Review
  13. Article
  14. Mediation CNN (Med-CNN) Model for High-Dimensional Mediation Data.International journal of molecular sciences · 2025
    Article
  15. Article
  16. International journal of molecular sciences · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Heliyon · 2024
    Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Donghyun KimCenter for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Korea.ORCID 0000-0002-5137-2213
Melody Y ZengDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
Gabriel NúñezDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
University of Michigan · USCatholic University of Korea · KR

Funding

Lung Immunopathology Training Stipend SupplementT32HL007517 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 1985 to 2022
$6.1M
Nod2: A Susceptibility Gene for Crohn's DiseaseR01DK061707 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2002 to 2017
$4.7M
The Role of Inflammasomes in Mucosal Immunity to Intestinal Bacterial PathogensR01DK091191 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2010 to 2019
$3.1M
NHLBI NIH HHS T32 HL007517NIDDK NIH HHS R01 DK061707NIDDK NIH HHS R01 DK091191
6 · The paper itself

Abstract

Many benefits provided by the gut microbiota to the host rely on its intricate interactions with host cells. Perturbations of the gut microbiota, termed gut dysbiosis, affect the interplay between the gut microbiota and host cells, resulting in dysregulation of inflammation that contributes to the pathogenesis of chronic inflammatory diseases, including inflammatory bowel disease, multiple sclerosis, allergic asthma and rheumatoid arthritis. In this review, we provide an overview of how gut bacteria modulates host metabolic and immune functions, summarize studies that examined the roles of gut dysbiosis in chronic inflammatory diseases, and finally discuss measures to correct gut dysbiosis as potential therapeutics for chronic inflammatory diseases.

Indexed as

Intestinal MucosaAnimalsArthritis, RheumatoidAsthmaBacteriaDysbiosisGastrointestinal MicrobiomeHumansInflammationInflammatory Bowel DiseasesMiceMultiple Sclerosis

Identifiers

PMID28546562
PMCPMC5454439
OpenAlexW2620068414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.